API Solutions

Dr. Reddy's API business supplies high-quality, affordable APIs to leading generic formulations manufacturers and is the preferred API partner for pharma companies in more than 100 countries. We thrive on the deep technical strengths proven over the last four decades in developing and manufacturing complex APIs. We focus our work on being first to market with products that are difficult to make.

  • solicon

    Abiraterone Acetate

  • solicon

    Acalabrutinib

  • solicon

    Dapagliflozin (Amorphous)

  • solicon

    Esomeprazole Magnesium Trihydrate

250+ API

100+ countries presence in

250+ R & D Experts

100+ DMFs

Who we are

Dr. Reddy's API business supplies high-quality, affordable APIs to leading generic formulations manufacturers and is the preferred API partner for pharma companies in more than 100 countries. We thrive on the deep technical strengths proven over the last four decades in developing and manufacturing complex APIs. We focus our work on being first to market with products that are difficult to make. We follow the latest quality, safety & productivity standards as per the ever-growing market needs. The success of our research organization is testimony to the fact that we have over 250+ APIs, 1900+ DMFs, 325+ ANDAs, and 86 patents filed in the last five years.

40+ Years

36 Drug Master Files

14 bold & ambitious goals

Meet with our product experts in one-on-one virtual sessions

Our experts will answer your questions, provide advice, Global Generics & stress timelines and help you understand our product better

Our Capabilities: Excellence in API Development

Leading the Way in API Manufacturing and Innovation

R&D

R&D

Your partner in complex API development. Proven expertise in niche areas. Accelerating drug discovery with our R&D prowess.

Regulatory Expertise

Regulatory Expertise

Comprehensive regulatory support to navigate global markets successfully.

Manufacturing Excellence

Manufacturing Excellence

State-of-the-art manufacturing. facilities across multiple locations, ensuring high quality and regulatory compliance.

Re-imagine API Sourcing with

Dr. Reddy’s Customer Engagement Platform offers a seamless experience for API sourcing.

Access detailed information about our API offerings

Simplified process for placing orders and making requests.

Track order and get updates: Real-time tracking and status updates on your orders,

Get personalized support: Dedicated support for your specific needs.

We are here to help, if you have any country specific requirements.

resource_main_image 1

Meeting the New Regulatory Requirements in Sartan API Production

  • {`small_banner_image_${i}`}

    Famotidine and Nizatidine APIs: NDMA controlled, customized particle distribution, supply chain security

  • {`small_banner_image_${i}`}

    Ruxolitinib falls under the drug class known as Janus kinase inhibitors (JAK inhibitors). It is an inhibitor of the JAK1 and JAK2 protein kinases and works by competitively inhibiting the ATP-binding catalytic site on JAK1 and JAK2.

  • {`small_banner_image_${i}`}

    Dr. Reddy's is an early mover in API development and planning to file the DMFs in key markets such as the US, China, Japan, Brazil, Europe, and Korea. We offer the anhydrous crystalline form (Innovator form).

Events

Upcoming events where Dr. Reddy’s API Specialists will be present

The CPHI Japan 2025
8-11 May 2025

The CPHI Japan 2025

  • event-loc Tokyo Big Sight in Tokyo, Japan
CPHI China 2025
24-26 June 2025

CPHI China 2025

  • event-loc Shanghai New International Expo Centre (SNIEC) in Shanghai, China
DCAT 2025
17-20 March 2025

DCAT 2025

  • event-loc New york

Awards

award_image 1
award_image 2
award_image 3

Our Sustainability and ESG Goals

Access

Affordability

Patient-centric Innovation